- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
News
Slideshow
Challenges and Emerging Therapies in CHE: Insights from Fall Clinical PA/NP 2025
Author(s):
At the Fall Clinical PA/NP 2025 Conference, attendees caught up on the ins and outs of CHE.
Chronic hand eczema (CHE) continues to pose a major dermatologic challenge due to its complex etiology, substantial patient burden, and absence of FDA-approved therapies for moderate to severe disease.1 At the 2025 Fall Clinical PA/NP Conference in Orlando, Florida, Andrea Murina, MD, and Linda Stein Gold, MD, led a dedicated session addressing the diagnosis, impact, and emerging treatment strategies for CHE.2
References
1. Weisshaar E. Chronic hand eczema. Am J Clin Dermatol. 2024;25(6):909-926. doi:10.1007/s40257-024-00890-z
2. Murina A, Stein Gold L. Seminar-in-depth: Turning a corner in diagnosis and treatment of chronic hand eczema. Presentation at Fall Clinical PA/NP 2025 Conference; May 30-June 2, 2025; Orlando, Florida.
3. Apfelbacher CJ, Ofenloch RF, Weisshaar E, et al. Chronic hand eczema in Germany: 5-year follow-up data from the CARPE registry. Contact Dermatitis. 2019;80(1):45-53. doi:10.1111/cod.13113
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
